PRDM4

Across TCGA pan-cancer cohorts, PRDM4 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PRDM4’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where PRDM4 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PRDM4 is over-expressed in tumor, although a few such as PDAC and HNSC show the opposite, repressed pattern.

PDAC and HNSC are the cancer types where PRDM4 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PRDM4 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	Male	All	−1.993	<.001	8	view →
HNSC	All	All	−0.520	.047	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

PRDM4–PDAC

Open the PDAC breakdown →